The Spinal Muscular Atrophy Market is Transforming Medical Therapeutics
Spinal muscular atrophy (SMA) is a group of hereditary autosomal recessive neuromuscular disorders that causes degeneration of motor neurons resulting in muscular atrophy and weakness. SMA afflicts approximately 1 out of every 11,000 live births and is the leading genetic cause of death for infants.